These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 9723482

  • 1. ABO-incompatible renal transplantation--dissociation of ABO antibodies.
    Uchida K, Tominaga Y, Haba T, Katayama A, Ichimori T, Yamada K, Hibi Y, Oikawa T, Takeda A, Morozumi K, Takagi H.
    Transplant Proc; 1998 Aug; 30(5):2302-3. PubMed ID: 9723482
    [No Abstract] [Full Text] [Related]

  • 2. Relation between ABO blood type antigen and antibody and acute vascular rejection in ABO incompatible kidney transplantation.
    Aikawa A, Hadano T, Ohara T, Hasegawa A, Yamashita M, Shindo M, Mizuiri T, Fushimi T, Sakai K, Hirayama N, Arai K, Tajima E.
    Transplant Proc; 1998 Nov; 30(7):3507-9. PubMed ID: 9838538
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of blood group antibodies in ABO-incompatible living-donor kidney transplantation.
    Sugiyama K, Hyodo Y, Aikawa A.
    Int J Urol; 2015 Oct; 22(10):931-6. PubMed ID: 26108258
    [Abstract] [Full Text] [Related]

  • 4. Significance of antidonor blood type antibody for long-term graft acceptance in ABO-incompatible kidney transplantation.
    Hadano T, Ohara T, Aikawa A, Hasegawa A.
    Transplant Proc; 2000 Nov; 32(7):1847-9. PubMed ID: 11119966
    [No Abstract] [Full Text] [Related]

  • 5. Pinpoint targeted immunosuppression: anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy.
    Saito K, Nakagawa Y, Suwa M, Kumagai N, Tanikawa T, Nishiyama T, Ueno M, Gejyo F, Nishi S, Takahashi K.
    Xenotransplantation; 2006 Mar; 13(2):111-7. PubMed ID: 16623803
    [Abstract] [Full Text] [Related]

  • 6. ABO-Incompatible kidney transplantation.
    Yaich S.
    Saudi J Kidney Dis Transpl; 2013 May; 24(3):463-72. PubMed ID: 23640616
    [Abstract] [Full Text] [Related]

  • 7. Current experience with renal transplantation across the ABO barrier.
    Nelson PW, Helling TS, Shield CF, Beck M, Bryan CF.
    Am J Surg; 1992 Nov; 164(5):541-4; discussion 544-5. PubMed ID: 1443385
    [Abstract] [Full Text] [Related]

  • 8. Comparative study of theefficacy of removal of anti-ABO and anti-gal antibodies by double filtration plasmapheresis.
    Kobayashi T, Yokoyama I, Morozumi K, Nagasaka T, Hayashi S, Uchida K, Takagi H, Nakao A.
    Xenotransplantation; 2000 May; 7(2):101-8. PubMed ID: 10961294
    [Abstract] [Full Text] [Related]

  • 9. The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment.
    Yoshimura N, Ushigome H, Matsuyama M, Nobori S, Suzuki T, Sakai K, Okajima H, Okamoto M.
    Transplant Proc; 2012 Jan; 44(1):140-3. PubMed ID: 22310599
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of 2 Doses of Rituximab on B-Cell and Antidonor Antibody and Outcomes of ABO-Incompatible Living-Donor Pediatric Kidney Transplant.
    Hamasaki Y, Aikawa A, Itabashi Y, Muramatsu M, Hyoudou Y, Shinoda K, Takahashi Y, Sakurabayashi K, Mizutani T, Oguchi H, Kawamura T, Sakai K, Shishido S.
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):105-109. PubMed ID: 30777532
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. ABO-incompatibility in solid organ transplantation.
    Rydberg L.
    Transfus Med; 2001 Aug; 11(4):325-42. PubMed ID: 11532188
    [Abstract] [Full Text] [Related]

  • 14. Chronic antibody-mediated rejection is reduced by targeting B-cell immunity during an introductory period.
    Kohei N, Hirai T, Omoto K, Ishida H, Tanabe K.
    Am J Transplant; 2012 Feb; 12(2):469-76. PubMed ID: 22054413
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Potent immunosuppression for ABO-incompatible renal transplantation may not be a risk factor for malignancy.
    Yamamoto T, Kawaguchi T, Watarai Y, Tujita M, Hiramitsu T, Nanmoku K, Goto N, Katayama A, Kobayashi T, Uchida K.
    Transplant Proc; 2012 Jan; 44(1):210-3. PubMed ID: 22310616
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
    Nakamura Y, Hama K, Iwamoto H, Yokoyama T, Kihara Y, Konno O, Jojima Y, Shimazu M.
    Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.